Gland Pharma Limited (BOM:543245)
India flag India · Delayed Price · Currency is INR
1,964.45
-16.60 (-0.84%)
At close: Aug 5, 2025

Gland Pharma Statistics

Total Valuation

Gland Pharma has a market cap or net worth of INR 323.70 billion. The enterprise value is 297.31 billion.

Market Cap323.70B
Enterprise Value 297.31B

Important Dates

The last earnings date was Friday, August 1, 2025.

Earnings Date Aug 1, 2025
Ex-Dividend Date Aug 14, 2025

Share Statistics

Current Share Class 164.76M
Shares Outstanding n/a
Shares Change (YoY) +0.01%
Shares Change (QoQ) -0.01%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 73.18M

Valuation Ratios

The trailing PE ratio is 42.03 and the forward PE ratio is 32.04.

PE Ratio 42.03
Forward PE 32.04
PS Ratio 5.65
PB Ratio 3.54
P/TBV Ratio 3.68
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 38.60
EV / Sales 5.19
EV / EBITDA 21.88
EV / EBIT 30.57
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.03
Debt / EBITDA 0.23
Debt / FCF n/a
Interest Coverage 22.47

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 6.55%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 13.16M
Profits Per Employee 1.77M
Employee Count4,286
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Gland Pharma has paid 3.87 billion in taxes.

Income Tax 3.87B
Effective Tax Rate 33.44%

Stock Price Statistics

The stock price has decreased by -7.68% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -7.68%
50-Day Moving Average 1,827.33
200-Day Moving Average 1,667.01
Relative Strength Index (RSI) 53.01
Average Volume (20 Days) 11,781

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Gland Pharma had revenue of INR 57.27 billion and earned 7.70 billion in profits. Earnings per share was 46.75.

Revenue57.27B
Gross Profit 33.08B
Operating Income 9.73B
Pretax Income 11.57B
Net Income 7.70B
EBITDA 13.40B
EBIT 9.73B
Earnings Per Share (EPS) 46.75
Full Income Statement

Balance Sheet

The company has 29.52 billion in cash and 3.14 billion in debt, giving a net cash position of 26.38 billion.

Cash & Cash Equivalents 29.52B
Total Debt 3.14B
Net Cash 26.38B
Net Cash Per Share n/a
Equity (Book Value) 91.51B
Book Value Per Share 555.41
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 57.77%, with operating and profit margins of 16.98% and 13.45%.

Gross Margin 57.77%
Operating Margin 16.98%
Pretax Margin 20.21%
Profit Margin 13.45%
EBITDA Margin 23.40%
EBIT Margin 16.98%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 18.00, which amounts to a dividend yield of 0.91%.

Dividend Per Share 18.00
Dividend Yield 0.91%
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield -0.01%
Shareholder Yield 0.90%
Earnings Yield 2.38%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3